Pharmacists unload the EpiVacCorona vaccine against COVID-19 developed by Novosibirsk's Vector State Research Center of Virology and Biotechnology at the pharmacy warehouse, in Volgograd, Russia.08.04.2021#6511719
Pharmacists unload the EpiVacCorona vaccine against COVID-19 developed by Novosibirsk's Vector State Research Center of Virology and Biotechnology at the pharmacy warehouse, in Volgograd, Russia.08.04.2021#6511716
The pharmacist unloads the EpiVacCorona vaccine against COVID-19 developed by Novosibirsk's Vector State Research Center of Virology and Biotechnology at the pharmacy warehouse, in Volgograd, Russia.08.04.2021#6511714
The pharmacist unloads the EpiVacCorona vaccine against COVID-19 developed by Novosibirsk's Vector State Research Center of Virology and Biotechnology at the pharmacy warehouse, in Volgograd, Russia.08.04.2021#6511713
The EpiVacCorona vaccine against COVID-19 developed by Novosibirsk's Vector State Research Center of Virology and Biotechnology is pictured at the pharmacy warehouse, in Volgograd, Russia.08.04.2021#6511709
The EpiVacCorona vaccine against COVID-19 developed by Novosibirsk's Vector State Research Center of Virology and Biotechnology is pictured at the pharmacy warehouse, in Volgograd, Russia.08.04.2021#6511708
The EpiVacCorona vaccine against COVID-19 developed by Novosibirsk's Vector State Research Center of Virology and Biotechnology is pictured at the pharmacy warehouse, in Volgograd, Russia.08.04.2021#6511707
The EpiVacCorona vaccine against COVID-19 developed by Novosibirsk's Vector State Research Center of Virology and Biotechnology is pictured at the pharmacy warehouse, in Volgograd, Russia.08.04.2021#6511706
The EpiVacCorona vaccine against COVID-19 developed by Novosibirsk's Vector State Research Center of Virology and Biotechnology is pictured at the pharmacy warehouse, in Volgograd, Russia.08.04.2021#6511704
The EpiVacCorona vaccine against COVID-19 developed by Novosibirsk's Vector State Research Center of Virology and Biotechnology is pictured at the pharmacy warehouse, in Volgograd, Russia.08.04.2021#6511703
The EpiVacCorona vaccine against COVID-19 developed by Novosibirsk's Vector State Research Center of Virology and Biotechnology is pictured at the pharmacy warehouse, in Volgograd, Russia.08.04.2021#6511702
A man delivers the EpiVacCorona vaccine against COVID-19 developed by Novosibirsk's Vector State Research Center of Virology and Biotechnology to the pharmacy warehouse, in Volgograd, Russia.08.04.2021#6511700
The EpiVacCorona vaccine against COVID-19 developed by Novosibirsk's Vector State Research Center of Virology and Biotechnology is pictured at the pharmacy warehouse, in Volgograd, Russia.08.04.2021#6511691
Director General of the Natsimbio holding Andrey Zagorsky is pictured at the company's warehouse of the logistics center where the EpiVacCorona vaccine against COVID-19 has delivered, outside Moscow, Russia.05.04.2021#6507410
A truck with the EpiVacCorona vaccine against COVID-19, developed by Novosibirsk's Vector State Research Center of Virology and Biotechnology, stands under unloading at the Natsimbio holding warehouse of the logistics center in Domodedovo, outside Moscow, Russia.05.04.2021#6507398
A worker unloads boxes with the EpiVacCorona vaccine against COVID-19, developed by Novosibirsk's Vector State Research Center of Virology and Biotechnology, delivered to the Natsimbio holding warehouse of the logistics center in Domodedovo for further distribution by regions, outside Moscow, Russia.05.04.2021#6507395
A worker unloads boxes with the EpiVacCorona vaccine against COVID-19, developed by Novosibirsk's Vector State Research Center of Virology and Biotechnology, delivered to the Natsimbio holding warehouse of the logistics center in Domodedovo for further distribution by regions, outside Moscow, Russia.05.04.2021#6507393
A worker unloads boxes with the EpiVacCorona vaccine against COVID-19, developed by Novosibirsk's Vector State Research Center of Virology and Biotechnology, delivered to the Natsimbio holding warehouse of the logistics center in Domodedovo for further distribution by regions, outside Moscow, Russia.05.04.2021#6507391
Workers unload boxes with the EpiVacCorona vaccine against COVID-19, developed by Novosibirsk's Vector State Research Center of Virology and Biotechnology, delivered to the Natsimbio holding warehouse of the logistics center in Domodedovo for further distribution by regions, outside Moscow, Russia.05.04.2021#6507390
A worker unloads boxes with the EpiVacCorona vaccine against COVID-19, developed by Novosibirsk's Vector State Research Center of Virology and Biotechnology, delivered to the Natsimbio holding warehouse of the logistics center in Domodedovo for further distribution by regions, outside Moscow, Russia.05.04.2021#6507389
A worker unloads boxes with the EpiVacCorona vaccine against COVID-19, developed by Novosibirsk's Vector State Research Center of Virology and Biotechnology, delivered to the Natsimbio holding warehouse of the logistics center in Domodedovo for further distribution by regions, outside Moscow, Russia.05.04.2021#6507386